WebSince 2012, Adam Stone has served as Chief Investment Officer of Perceptive Advisors, which he joined in 2006, and is a member of the internal investment committees of Perceptive Advisors’ credit … WebMr. Stone is member of the board of directors for Solid Biosciences. In 2006 Mr. Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During …

Stamford’s SpringWorks Therapeutics pulls in nine-figure financing

WebAdam Stone Chief Investment Officer & Head of Research. In 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five … Founded in 1999, Perceptive Advisors focuses on supporting progress in the … WebJun 16, 2024 · “ C4 Therapeutics is a pioneer in this exciting and promising new protein degradation space,” said Adam Stone, Chief Investment Officer of Perceptive Advisors and co-lead of this financing. jim brown singer

Adam Stone Email & Phone Number - Perceptive Ad.. ZoomInfo

WebDr. Craig Yeshion serves as Managing Director at Perceptive Advisors. Dr. Yeshion joined Perceptive in 2016. Prior to joining the firm, he was a Portfolio Manager for J. Goldman & Co. covering medical devices and diagnostics from 2012 through 2016. Prior to J. Goldman, he spent 5 years covering medical devices, and biotechnology as a Senior ... WebXontogeny was founded by industry veteran, Chris Garabedian, who will serve as Chairman and CEO. Perceptive Advisors, the exclusive institutional investor in the Series A financing, will be represented on Xontogeny's Board of Directors by Joseph Edelman, Perceptive's Chief Executive Officer and Adam Stone, Perceptive's Chief Investment Officer. WebIn 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there Adam focused on biotech and specialty … jim brown slaughter